Silence Therapeutics (SLN)

NASDAQ: SLN · Real-Time Price · USD

4.23

0.22 (5.49%)

At close: May 02, 2025, 12:47 PM

Silence Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	121.33M	54.03M	54.82M	73.54M	27.45M	13.52M	21.49M	42.74M	39.01M
Short-Term Investments	26M	n/a	16.33M	n/a	10M	20M	5.04M	319K	3K
Long-Term Investments	n/a	284K	284K	301K	303K	-19.73M	-4.77M	n/a	4.42M
Other Long-Term Assets	3.59M	2.58M	-10.81M	-9.86M	-9.57M	20M	5.04M	233K	239K
Receivables	n/a	228K	17.34M	8.49M	29.31M	3.52M	n/a	n/a	810K
Inventory	n/a	n/a	-16.43M	1.00	1.49M	n/a	-2.45M	-2.48M	-2.99M
Other Current Assets	n/a	n/a	n/a	n/a	5.7M	n/a	n/a	n/a	1.9M
Total Current Assets	187.37M	81.02M	96.69M	86.33M	76.4M	37.47M	29.5M	45.55M	42.01M
Property-Plant & Equipment	1.98M	1.81M	2.2M	1.94M	1.13M	611K	921K	1.17M	1.38M
Goodwill & Intangibles	9.7M	8.12M	8.33M	7.62M	8.14M	7.73M	8.19M	8.06M	7.75M
Total Long-Term Assets	15.27M	12.8M	10.81M	9.86M	9.57M	8.61M	9.39M	9.46M	13.78M
Total Assets	202.63M	93.82M	107.5M	96.19M	85.97M	46.08M	38.88M	55.01M	55.79M
Account Payables	3.7M	2.63M	3.19M	4.07M	2.29M	1.79M	1.15M	462K	528K
Deferred Revenue	306K	n/a	8.86M	4.25M	17.04M	2.48M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.44M	6.11M	589K	185K	17.04M	2.48M	27K	n/a	n/a
Total Current Liabilities	16.82M	17.77M	21.94M	15.17M	25.57M	9.65M	3.83M	2.66M	1.61M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	51.79M	59M	63.48M	72.5M	51.34M	15.52M	1.15M	462K	528K
Total Liabilities	68.61M	76.77M	85.43M	87.67M	76.91M	25.17M	3.83M	2.66M	1.61M
Total Debt	117K	272K	446K	137K	341K	287K	n/a	n/a	n/a
Common Stock	n/a	5.94M	5.39M	4.49M	4.17M	3.92M	3.55M	3.5M	3.49M
Retained Earnings	-474.04M	-304.61M	-263.26M	-222.97M	-184.22M	-152M	-133.78M	-116.43M	-115.95M
Comprehensive Income	-11.78M	64.27M	24.33M	23.79M	189.11M	168.99M	165.28M	165.28M	166.64M
Shareholders Equity	134.02M	17.05M	22.07M	8.53M	9.06M	20.91M	35.05M	52.35M	54.18M
Total Investments	26M	284K	16.61M	301K	303K	275K	275K	319K	4.42M